Insider Shareholders with Direct Ownership of Eledon Pharmaceuticals, Inc. (ELDN)
This section provides a comprehensive overview of the insiders with direct ownership of Eledon Pharmaceuticals, Inc. (ELDN). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Eledon Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Novartis Bioventures Ltd
> 10% Shareholder |
4,644,328 | 150,870 | 4,493,458 $19.6 Million | 10 |
Jul 15, 2015
Reduced 0.08%
|
|
Bvf Partners L P
> 10% Shareholder |
5,196,497 | 0 | 220,460 $961,205 | 3 |
May 09, 2024
Added 25.49%
|
|
Paul Sean Little
Chief Financial Officer |
10,000 | 0 | 10,000 $43,600 | 1 |
Jun 11, 2021
Added 50.0%
|
|
David Alexandre C Gros
Chief Executive Officer |
9,000 | 0 | 9,000 $39,240 | 3 |
Dec 20, 2021
Added 18.18%
|
|
Steven Perrin
President |
1,000 | 0 | 1,000 $4,360 | 1 |
Nov 23, 2022
Added 50.0%
|